BMRN
BioMarin Pharmaceutical Inc.
$52.53
+$1.06(+2.07%)
56
Overall
80
Value
30
Tech
60
Quality
Market Cap
$10.23B
Volume
1.04M
52W Range
$50.76 - $73.51
Target Price
$90.65
EPS Estimates Overview
| Current Quarter | $0.77 | Next Quarter | $1.09 |
| Current Year | $3.09 | Next Year | $4.59 |
| QoQ Growth | +41.6% | YoY Growth | +48.5% |
| 3Y EPS CAGR | +1.0% | Target Price | $90.65 |
| Consensus | Buy | Upside | +72.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BMRN | $52.53 | +2.1% | 1.04M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioMarin Pharmaceutical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW